BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9720620)

  • 1. Acid-catalysed hydrolysis and benzodiazepine-like properties of 5-(dialkylamino)- and 5-(alkylthio)-substituted 8-chloro-6-phenyl-6H-[1,2,4]triazolol[4,3-a][1,5]benzodiazepines in mice.
    Caccia S; Grossi G; Fracasso C; Nacca A; Cagnotto A; Mennini T; Ghia M; Roma G
    J Pharm Pharmacol; 1998 Jul; 50(7):723-8. PubMed ID: 9720620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations.
    Shafie A; Mohammadi-Khanaposhtani M; Asadi M; Rahimi N; Ranjbar PR; Ghasemi JB; Larijani B; Mahdavi M; Shafaroodi H; Dehpour AR
    Mol Divers; 2020 Feb; 24(1):179-189. PubMed ID: 30895449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, receptor affinity and effect on pentylenetetrazole-induced seizure threshold of novel benzodiazepine analogues: 3-Substituted 5-(2-phenoxybenzyl)-4H-1,2,4-triazoles and 2-amino-5-(phenoxybenzyl)-1,3,4-oxadiazoles.
    Mashayekh S; Rahmanipour N; Mahmoodi B; Ahmadi F; Motaharian D; Shahhosseini S; Shafaroodi H; Banafshe HR; Shafiee A; Navidpour L
    Bioorg Med Chem; 2014 Mar; 22(6):1929-37. PubMed ID: 24530225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-[Aryloxypyridyl (or nitrophenyl)]-4H-1,2,4-triazoles as novel flexible benzodiazepine analogues: Synthesis, receptor binding affinity and lipophilicity-dependent anti-seizure onset of action.
    Navidpour L; Shabani S; Heidari A; Bashiri M; Ebrahim-Habibi A; Shahhosseini S; Shafaroodi H; Abbas Tabatabai S; Toolabi M
    Bioorg Chem; 2021 Jan; 106():104504. PubMed ID: 33279247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aryl-3-(alkylthio)-4H-1,2,4-triazoles as selective antagonists of strychnine-induced convulsions and potential antispastic agents.
    Kane JM; Staeger MA; Dalton CR; Miller FP; Dudley MW; Ogden AM; Kehne JH; Ketteler HJ; McCloskey TC; Senyah Y
    J Med Chem; 1994 Jan; 37(1):125-32. PubMed ID: 8289185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,5-Benzodiazepine tricyclic derivatives exerting anti-inflammatory effects in mice by inhibiting interleukin-6 and prostaglandinE(2)production.
    Fruscella P; Sottocorno M; Di Braccio M; Diomede L; Piccardi N; Cagnotto A; Grossi G; Romano M; Mennini T; Roma G
    Pharmacol Res; 2001 May; 43(5):445-52. PubMed ID: 11394936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one and Its Derivatives.
    Zhang HJ; Jin P; Wang SB; Li FN; Guan LP; Quan ZS
    Arch Pharm (Weinheim); 2015 Aug; 348(8):564-74. PubMed ID: 26053879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Evaluation of the Anticonvulsant Activities of 4-(2-(Alkylthio)benzo[d]oxazol-5-yl)-2,4-dihydro-3H-1,2,4-triazol-3-ones.
    Song MX; Wang ZY; He SH; Yu SW; Chen SL; Guo DF; Zhao WH; Deng XQ
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29587394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel GABA(A) alpha 5 receptor inhibitor with therapeutic potential.
    Ling I; Mihalik B; Etherington LA; Kapus G; Pálvölgyi A; Gigler G; Kertész S; Gaál A; Pallagi K; Kiricsi P; Szabó É; Szénási G; Papp L; Hársing LG; Lévay G; Spedding M; Lambert JJ; Belelli D; Barkóczy J; Volk B; Simig G; Gacsályi I; Antoni FA
    Eur J Pharmacol; 2015 Oct; 764():497-507. PubMed ID: 26169564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models.
    Rivas FM; Stables JP; Murphree L; Edwankar RV; Edwankar CR; Huang S; Jain HD; Zhou H; Majumder S; Sankar S; Roth BL; Ramerstorfer J; Furtmüller R; Sieghart W; Cook JM
    J Med Chem; 2009 Apr; 52(7):1795-8. PubMed ID: 19275170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of pharmacological and pharmacokinetic properties of 11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepin-3(2H)-ones.
    Zappalà M; Gitto R; Bevacqua F; Quartarone S; Chimirri A; Rizzo M; De Sarro G; De Sarro A
    J Med Chem; 2000 Dec; 43(25):4834-9. PubMed ID: 11123993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
    Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the involvement of the GABA-ergic pathway in the anticonvulsant activity of the roots bark aqueous extract of Anthocleista djalonensis A. Chev. (Loganiaceae).
    Taiwe GS; Kouamou ALN; Ambassa ARM; Menanga JR; Tchoya TB; Dzeufiet PDD
    J Basic Clin Physiol Pharmacol; 2017 Sep; 28(5):425-435. PubMed ID: 28777735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Pharmacological Evaluation of New 3,4-Dihydroisoquinolin Derivatives Containing Heterocycle as Potential Anticonvulsant Agents.
    Zhang HJ; Shen QK; Jin CM; Quan ZS
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27916842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticonvulsant activity of N-3 substituted 2,3-benzodiazepines.
    Quartarone S; Caruso R; Orlando V; Russo E; De Sarro G; Chimirri A
    Farmaco; 2004 May; 59(5):353-8. PubMed ID: 15120314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
    Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
    J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
    Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG
    J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD; Honoré T; Iversen SD; Kemp JA; Knight AR; Marshall GR; Rupniak NM; Singh L; Tye S; Watjen F
    Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepine receptor ligands. Synthesis and preliminary pharmacological evaluation of 2-aminoalkyl-8-chloro- and 2-aryl-1,2,4-triazolo[3,4-a]phthalazine-3(2H)-ones.
    Tarzia G; Occelli E; Corsico N; Gallico L; Luzzani F; Barone D
    Farmaco; 1989 Jan; 44(1):17-28. PubMed ID: 2545219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.